Baliopharm Overview
- Founded
- 2011

- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
- Investments
- 1
Baliopharm General Information
Description
Developer of biotechnological therapeutic drugs in Basel, Switzerland. The company's products include therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn's disease, psoriasis and multiple sclerosis, enabling physicians and doctors to enhance their treatment procedures.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Primary Office
- Stänzlergasse 4
- 4051 Basel
- Switzerland
+41 061 000 00 00
Baliopharm Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Baliopharm‘s full profile, request access.
Request a free trialBaliopharm Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biotechnological therapeutic drugs in Basel, Switzerland. The company's products include therapeutics for t
Biotechnology
Basel, Switzerland
000000&0
00000000
sse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000000000000
Pratteln, Switzerland
000
As of 0000
00000
000000000
00000
0000000
dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
0000000000000
Wilmington, DE
00.00
0000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialBaliopharm Competitors (19)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Santhera Pharmaceuticals | Formerly VC-backed | Pratteln, Switzerland | 000 | 00000 | 000000000 | 00000 |
0000000 | Accelerator/Incubator Backed | Wilmington, DE | 00.00 | 0000000000 | ||
000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 0 | 000.00 |
00000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 0000000000. | |
000000000 00000000 | Formerly VC-backed | Boston, MA | 00 | 00000 | 000000000 | 00000 |
Baliopharm Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Andreas Herrmann Ph.D | Chief Executive Officer |
Baliopharm Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00 000000000000000 | 05-Jul-2016 | 0000 00000 | 00000 | Drug Discovery |